Pharmafile Logo
Pharmafocus logo
Advanced Search

National campaign promotes private healthcare

November 1, 2005
Sales and Marketing

Six of the UK's biggest private hospital and health insurance companies have joined forces to promote the benefits of private …

News

Tropical disease research centre to open in Liverpool

October 31, 2005
Research and Development

A new UK research centre specialising in the development of new tropical medicines has been given the go-ahead with £18 …

News

Campaigners dismayed at unworkable partial smoking ban

October 28, 2005
Research and Development

Doctors and health campaigners have expressed their deep disappointment over the government's failure to introduce a complete smoking ban in …

News

UK patients invited to report side-effects

October 28, 2005
Sales and Marketing

Members of the public will now be able to report adverse events in medicines direct to the UK watchdog through …

News

Merck and Schering-Plough lifted by cholesterol joint venture

October 26, 2005
Sales and Marketing

A marketing alliance between Merck and Schering-Plough has given the troubled companies some positive news to report.Global sales of the …

News

Markets shocked by Pfizer sales slump

October 26, 2005
Sales and Marketing

Pfizer, the pharma industry's powerhouse, has suffered a 52% slump in profits in the third quarter, undermining investor confidence in …

News

Marketing a high priority – but budgets still a battle

October 26, 2005
Sales and Marketing

A survey of marketers across industry sectors has underlined the importance of their role  but shows many have to battle …

News

Can the NHS become a world-class healthcare system?

October 25, 2005
Sales and Marketing

Tony Blair and Labour were re-elected in May this year for an historic third-term, with the electorate telling pollsters they …

News

Oxford BioMedica’s lung cancer candidate shows promise

October 25, 2005
Research and Development

A promising antibody developed by UK-based Oxford BioMedica is poised to enter clinical trials to treat lung cancer.The 5T4 antibody-targeted …

News

Pharma continues to invest in UK research and development

October 24, 2005
Sales and Marketing Pfizer, R&D

 UK pharma and biotech companies increased R&D investment by 4% in the last year, according to the latest government figures.The …

News

Blockbuster partnerships

October 21, 2005
Research and Development

Since pharma'ps big wave of innovation during the early 1990s, peaking in 1996 when 131 new drug applications were filed …

Feature

Vaccine companies to compete for UK pandemic contract

October 20, 2005
Sales and Marketing

Vaccine companies are to compete with each other to produce a vaccine against a potential pandemic flu – although no-one …

News

New approvals in TNF-blocker class

October 20, 2005
Sales and Marketing

Competition in one of the industry's fastest growing markets is intensifying with new approvals for two TNF-blocker drugs.Schering-Plough and Centocor's …

News

Resolute wins PR Consultancy of the Year award

October 20, 2005
Medical Communications

Healthcare agency Resolute Communications has been named consultancy of the year at the PRWeek awards, believed to be the first …

News

Once a day pill promises period-free contraception

October 20, 2005
Sales and Marketing

The world's first-ever contraceptive pill to offer women complete freedom from menstruation could be launched by next year.Wyeth's Lybrel is …

News

Tarceva/Avastin combination disappoints in kidney cancer

October 19, 2005
Sales and Marketing

Early results from trials suggest adding Tarceva to Avastin has no extra benefit in the treatment of kidney cancer.Researchers at …

News

Pharma – partners of NHS choice?

October 19, 2005

The government sees choice as a major driver for promoting quality, responsiveness, efficiency and equity in public services. Choice in …

Feature

Merck to co-develop novel prostate cancer candidate

October 18, 2005
Research and Development

Merck is to develop a new monoclonal antibody which has shown promise in treating prostate cancer.The US company has signed …

News

Exubera recommended by European regulator

October 18, 2005
Sales and Marketing

Exubera, the first ever inhaled insulin product is set for approval in Europe following a key regulatory recommendation.The positive opinion …

News

Winning CROs look east for expansion

October 18, 2005
Research and Development

The new onus on outsourcing has seen CROs reap the benefits of an industry striving to cut resource investment while …

Feature
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026